187 related articles for article (PubMed ID: 33413710)
21. Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia: A Phase I Randomized Clinical Trial.
Maltête D; Wallon D; Bourilhon J; Lefaucheur R; Danaila T; Thobois S; Defebvre L; Dujardin K; Houeto JL; Godefroy O; Krystkowiak P; Martinaud O; Gillibert A; Chastan M; Vera P; Hannequin D; Welter ML; Derrey S
Neurology; 2021 Feb; 96(5):e684-e697. PubMed ID: 33199437
[TBL] [Abstract][Full Text] [Related]
22. Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer's disease progression.
Shafiee N; Fonov V; Dadar M; Spreng RN; Collins DL
Neurobiol Aging; 2024 Jul; 139():54-63. PubMed ID: 38608458
[TBL] [Abstract][Full Text] [Related]
23. Altered Nucleus Basalis Connectivity Predicts Treatment Response in Mild Cognitive Impairment.
Meng D; Li X; Bauer M; Taylor JP; Auer DP;
Radiology; 2018 Dec; 289(3):775-785. PubMed ID: 30204076
[TBL] [Abstract][Full Text] [Related]
24. Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.
Lin CP; Frigerio I; Boon BDC; Zhou Z; Rozemuller AJM; Bouwman FH; Schoonheim MM; van de Berg WDJ; Jonkman LE
Brain; 2022 Aug; 145(8):2869-2881. PubMed ID: 35259207
[TBL] [Abstract][Full Text] [Related]
25. Nucleus basalis of Meynert neuronal activity in Parkinson's disease.
Lee DJ; Milosevic L; Gramer R; Sasikumar S; Al-Ozzi TM; De Vloo P; Dallapiazza RF; Elias GJB; Cohn M; Kalia SK; Hutchison WD; Fasano A; Lozano AM
J Neurosurg; 2019 Feb; 132(2):574-582. PubMed ID: 30797189
[TBL] [Abstract][Full Text] [Related]
26. Structural degeneration of the nucleus basalis of Meynert in mild cognitive impairment and Alzheimer's disease - Evidence from an MRI-based meta-analysis.
Mieling M; Meier H; Bunzeck N
Neurosci Biobehav Rev; 2023 Nov; 154():105393. PubMed ID: 37717861
[TBL] [Abstract][Full Text] [Related]
27. Are Linear Measurements of the Nucleus Basalis of Meynert Suitable as a Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer Disease?
Jethwa KD; Dhillon P; Meng D; Auer DP;
AJNR Am J Neuroradiol; 2019 Dec; 40(12):2039-2044. PubMed ID: 31727757
[TBL] [Abstract][Full Text] [Related]
28. Increased functional connectivity between nucleus basalis of Meynert and amygdala in cognitively intact elderly along the Alzheimer's continuum.
Zeng Q; Qiu T; Li K; Luo X; Wang S; Xu X; Liu X; Hong L; Li J; Huang P; Zhang M;
Neuroimage Clin; 2022; 36():103256. PubMed ID: 36451361
[TBL] [Abstract][Full Text] [Related]
29. Deep brain stimulation of the nucleus basalis of Meynert attenuates early EEG components associated with defective sensory gating in patients with Alzheimer disease - a two-case study.
Dürschmid S; Reichert C; Kuhn J; Freund HJ; Hinrichs H; Heinze HJ
Eur J Neurosci; 2020 Mar; 51(5):1201-1209. PubMed ID: 29055119
[TBL] [Abstract][Full Text] [Related]
30. Whole-brain neural connectivity to cholinergic neurons in the nucleus basalis of Meynert.
Chen ZY; Yang YL; Li M; Gao L; Qu WM; Huang ZL; Yuan XS
J Neurochem; 2023 Jul; 166(2):233-247. PubMed ID: 37353897
[TBL] [Abstract][Full Text] [Related]
31. Deep Brain Stimulation in Alzheimer's Disease: Targeting the Nucleus Basalis of Meynert.
Chen YS; Shu K; Kang HC
J Alzheimers Dis; 2021; 80(1):53-70. PubMed ID: 33492288
[TBL] [Abstract][Full Text] [Related]
32. A New Neural Pathway from the Ventral Striatum to the Nucleus Basalis of Meynert with Functional Implication to Learning and Memory.
Shu SY; Jiang G; Zheng Z; Ma L; Wang B; Zeng Q; Li H; Tan S; Liu B; Chan WY; Wu S; Zhu C; Li C; Wang P; Wu JY
Mol Neurobiol; 2019 Oct; 56(10):7222-7233. PubMed ID: 31001802
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease.
Szigeti C; Bencsik N; Simonka AJ; Legradi A; Kasa P; Gulya K
Brain Res Bull; 2013 May; 94():9-16. PubMed ID: 23357177
[TBL] [Abstract][Full Text] [Related]
34. Degeneration of cholinergic white matter pathways and nucleus basalis of Meynert in individuals with objective subtle cognitive impairment.
Qiu T; Hong H; Zeng Q; Luo X; Wang X; Xu X; Xie F; Li X; Li K; Huang P; Dai S; Zhang M;
Neurobiol Aging; 2023 Dec; 132():198-208. PubMed ID: 37852044
[TBL] [Abstract][Full Text] [Related]
35. Daytime sleepiness in dementia with Lewy bodies is associated with neuronal depletion of the nucleus basalis of Meynert.
Kasanuki K; Ferman TJ; Murray ME; Heckman MG; Pedraza O; Hanna Al-Shaikh FS; Mishima T; Diehl NN; van Gerpen JA; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
Parkinsonism Relat Disord; 2018 May; 50():99-103. PubMed ID: 29429645
[TBL] [Abstract][Full Text] [Related]
36. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960
[TBL] [Abstract][Full Text] [Related]
37. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
Lippa CF; Smith TW; Perry E
J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
[TBL] [Abstract][Full Text] [Related]
38. Nucleus basalis of Meynert modulates signal processing in rat layer 5 somatosensory cortex but leads to memory impairment and tactile discrimination deficits following lesion.
Goshadrou F; Sadeghi B
Behav Brain Res; 2020 May; 386():112608. PubMed ID: 32194192
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of galanin in the cholinergic basal forebrain of patients with Lewy body disorders.
Alexandris A; Liu AK; Chang RC; Pearce RK; Gentleman SM
Acta Neuropathol Commun; 2015 Dec; 3():77. PubMed ID: 26621352
[TBL] [Abstract][Full Text] [Related]
40. Nucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson's disease.
Wilson H; de Natale ER; Politis M
Handb Clin Neurol; 2021; 179():189-205. PubMed ID: 34225962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]